Presentation Information

[27-15-pm15S]The development of hepatocyte-specific drug delivery carrier using Hepatitis B virus-like particles (VLP).

○Eri Takayama1, Yuki Iwaisako1, Keiji Ueda2, Masahiro Fujimuro1 (1. Kyoto Pharmaceutical University, 2. Osaka University Graduate School of Medicine)